Iliad Research & Trading, L.P. 13D and 13G filings for CardioGenics Holdings Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-11 11:49 am Unchanged |
2025-03-11 | 13G | CardioGenics Holdings Inc CGNH |
Iliad Research & Trading, L.P. | 2,415,275 9.900% |
0 (Unchanged) |
Filing |
| 2024-02-26 11:25 am Unchanged |
2024-02-26 | 13G | CardioGenics Holdings Inc CGNH |
Iliad Research & Trading, L.P. | 2,415,275 9.990% |
0 (Unchanged) |
Filing |
| 2023-02-14 10:24 am Unchanged |
2023-02-14 | 13G | CardioGenics Holdings Inc CGNH |
Iliad Research & Trading, L.P. | 2,415,275 9.990% |
0 (Unchanged) |
Filing |
| 2022-02-07 4:51 pm Unchanged |
2022-02-07 | 13G | CardioGenics Holdings Inc CGNH |
Iliad Research & Trading, L.P. | 2,415,275 9.990% |
0 (Unchanged) |
Filing |
| 2021-01-22 2:43 pm Unchanged |
2021-01-22 | 13G | CardioGenics Holdings Inc CGNH |
Iliad Research & Trading, L.P. | 2,415,275 9.990% |
0 (Unchanged) |
Filing |